# Merit Medical Systems, Inc. (MMSI) Stock Analysis: A 21.93% Upside Potential Beckons Investors

- Link: https://www.directorstalkinterviews.com/merit-medical-systems-inc-mmsi-stock-analysis-a-21-93-upside-potential-beckons-investors/4121256187
- Published: 2026-07-13T10:24:13+01:00
- Author: Madison Wilson

Merit Medical Systems, Inc. (NASDAQ: MMSI) stands out in the healthcare sector, 
specifically in the medical instruments and supplies industry, with a robust market
capitalization of $4.38 billion. This U.S.-based company, headquartered in South
Jordan, Utah, continues to capture investor interest with its innovative single-
use medical products designed for interventional, diagnostic, and therapeutic procedures.
Its operations extend across the globe, with a significant presence in countries
like China, Japan, Germany, and the United Kingdom.

The company’s current stock price of $73.44, with a modest price change of 0.03%,
has been navigating within a 52-week range of $60.31 to $93.60. However, the stock’s
recent dip provides an intriguing entry point for investors, especially with a potential
upside of 21.93% based on the average target price of $89.55 set by analysts. The
50-day moving average of $65.63 suggests a short-term bullish trend, despite the
200-day moving average being slightly higher at $76.47.

Merit Medical’s forward P/E ratio of 16.70 positions it attractively within its 
industry, indicating potential growth. Although some valuation metrics like P/E 
ratio (trailing) and PEG ratio remain unavailable, the company’s revenue growth 
rate of 7.50% underscores its operational efficiency and market demand. With an 
EPS of 2.32 and a return on equity of 9.12%, the company demonstrates a strong capacity
to generate profits relative to shareholder equity.

While Merit Medical does not offer a dividend, evident from a payout ratio of 0.00%,
it compensates with a healthy free cash flow of approximately $178.2 million, which
can be reinvested into the business for further expansion and innovation. This strategy
aligns with the company’s focus on enhancing its product offerings across its Cardiovascular
and Endoscopy segments, including micropuncture kits, angiographic needles, and 
oncology products.

Analysts are bullish on Merit Medical, with 9 buy ratings and only 2 hold ratings,
and no sell ratings, reflecting confidence in the company’s growth trajectory and
market position. The target price range extends from $74.00 to $110.00, further 
supporting the potential for substantial returns.

Technically, the stock’s RSI (14) of 27.36 indicates it is in oversold territory,
suggesting a potential rebound. The MACD of 1.82, with the signal line at 1.57, 
also points toward bullish momentum.

Merit Medical Systems’ strategic focus on product innovation and global expansion,
coupled with the strong analyst endorsement and technical indicators, makes it an
appealing consideration for investors looking to capitalize on growth opportunities
in the healthcare sector. As the company continues to enhance its product portfolio
and expand its international footprint, it remains well-positioned to deliver value
to shareholders.

Share on: